Dr. Heath Latham, M.D

NPI: 1639210123
Total Payments
$9,676
2024 Payments
$15.13
Companies
10
Transactions
36
Medicare Patients
2,340
Medicare Billing
$223,869

Payment Breakdown by Category

Consulting$6,525 (67.4%)
Travel$1,209 (12.5%)
Other$1,020 (10.5%)
Food & Beverage$864.59 (8.9%)
Education$57.74 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $6,525 5 67.4%
Travel and Lodging $1,209 5 12.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,020 1 10.5%
Food and Beverage $864.59 23 8.9%
Education $57.74 2 0.6%

Top Paying Companies

Company Total Records Latest Year
Baxter Healthcare $5,911 5 $0 (2023)
VERTEX PHARMACEUTICALS INCORPORATED $1,434 9 $0 (2019)
Genentech USA, Inc. $1,020 1 $0 (2021)
Cheetah Medical, Inc. $750.00 1 $0 (2017)
GlaxoSmithKline, LLC. $174.68 12 $0 (2024)
La Jolla Pharmaceutical Company $161.50 2 $0 (2022)
Regeneron Healthcare Solutions, Inc. $122.55 1 $0 (2021)
AstraZeneca Pharmaceuticals LP $60.74 2 $0 (2022)
Allergan Inc. $24.85 2 $0 (2017)
Insmed, Inc. $16.24 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $15.13 1 GlaxoSmithKline, LLC. ($15.13)
2023 $3,299 4 Baxter Healthcare ($3,273)
2022 $2,799 6 Baxter Healthcare ($2,639)
2021 $1,252 7 Genentech USA, Inc. ($1,020)
2020 $23.86 2 GlaxoSmithKline, LLC. ($23.86)
2019 $1,478 12 VERTEX PHARMACEUTICALS INCORPORATED ($1,434)
2017 $809.33 4 Cheetah Medical, Inc. ($750.00)

All Payment Transactions

36 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
01/19/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.13 General
Category: RESPIRATORY
08/10/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $12.96 General
Category: RESPIRATORY
03/23/2023 Baxter Healthcare STARLING SYSTEM (Device) Consulting Fee Cash or cash equivalent $1,347.50 General
Category: Fluid Systems
02/10/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.66 General
Category: RESPIRATORY
02/06/2023 Baxter Healthcare STARLING SYSTEM (Device) Consulting Fee Cash or cash equivalent $1,925.00 General
Category: Fluid Systems
11/19/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.66 General
Category: RESPIRATORY
11/09/2022 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $26.26 General
Category: Respiratory
11/03/2022 Baxter Healthcare STARLING SYSTEM (Device) Consulting Fee Cash or cash equivalent $1,925.00 General
Category: Fluid Systems
10/18/2022 Baxter Healthcare Renal - Acute (Device) Food and Beverage In-kind items and services $136.49 General
Category: Renal
05/05/2022 La Jolla Pharmaceutical Company GIAPREZA (Drug) Food and Beverage In-kind items and services $120.00 General
Category: EMERGENT HYPOTENSION
01/20/2022 Baxter Healthcare Renal - Acute (Device) Consulting Fee Cash or cash equivalent $577.50 General
Category: Renal
12/03/2021 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $122.55 General
Category: INFLAMMATION AND IMMUNOLOGY
11/18/2021 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $17.47 General
Category: IMMUNOLOGY
06/03/2021 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $15.07 General
Category: IMMUNOLOGY
05/25/2021 Genentech USA, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,020.00 General
05/10/2021 La Jolla Pharmaceutical Company GIAPREZA (Drug) Education In-kind items and services $41.50 General
Category: EMERGENT HYPOTENSION
04/29/2021 Insmed, Inc. Arikayce (Drug) Education In-kind items and services $16.24 General
Category: Respiratory
03/18/2021 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $19.06 General
Category: IMMUNOLOGY
11/12/2020 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $11.26 General
Category: RESPIRATORY
10/08/2020 GlaxoSmithKline, LLC. ANORO ELLIPTA (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $12.60 General
Category: RESPIRATORY
11/14/2019 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $15.87 General
Category: RESPIRATORY
10/28/2019 VERTEX PHARMACEUTICALS INCORPORATED Travel and Lodging In-kind items and services $198.41 General
10/28/2019 VERTEX PHARMACEUTICALS INCORPORATED Travel and Lodging In-kind items and services $155.79 General
10/28/2019 VERTEX PHARMACEUTICALS INCORPORATED Travel and Lodging In-kind items and services $84.60 General
10/28/2019 VERTEX PHARMACEUTICALS INCORPORATED Food and Beverage In-kind items and services $60.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 500 645 $184,574 $48,330
2022 13 542 692 $187,159 $52,279
2021 8 341 509 $179,085 $58,353
2020 14 957 1,172 $269,569 $64,907
Total Patients
2,340
Total Services
3,018
Medicare Billing
$223,869
Procedure Codes
58

All Medicare Procedures & Services

58 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 40 85 $60,678 $13,511 22.3%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 60 113 $29,813 $10,269 34.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 73 82 $15,266 $5,444 35.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 41 41 $18,421 $5,413 29.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 41 51 $9,847 $3,506 35.6%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 24 24 $8,069 $2,876 35.6%
99292 Critical care, each additional 30 minutes Facility 2023 11 30 $10,130 $2,443 24.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 27 34 $6,122 $2,054 33.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 22 24 $3,276 $1,106 33.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 14 14 $1,904 $653.38 34.3%
94726 Test to determine lung volumes using sensors Facility 2023 36 36 $9,724 $322.82 3.3%
94729 Test to examine how well the lungs exchange gases Facility 2023 44 44 $1,056 $286.15 27.1%
94010 Test to measure expiratory airflow and volume Facility 2023 42 42 $6,054 $251.46 4.2%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2023 14 14 $3,780 $103.90 2.7%
94727 Test to determine lung volumes using gas dilution or washout Facility 2023 11 11 $434.00 $91.70 21.1%
99291 Critical care, first 30-74 minutes Facility 2022 43 103 $63,750 $16,701 26.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 71 111 $27,195 $8,460 31.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 68 77 $12,119 $5,070 41.8%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 35 35 $10,698 $4,489 42.0%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 27 27 $12,825 $4,083 31.8%
99292 Critical care, each additional 30 minutes Facility 2022 22 44 $13,560 $3,656 27.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 33 40 $6,544 $2,329 35.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 24 33 $5,610 $1,789 31.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 12 12 $3,704 $1,670 45.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 27 29 $3,806 $1,332 35.0%

About Dr. Heath Latham, M.D

Dr. Heath Latham, M.D is a Critical Care Medicine healthcare provider based in Kansas City, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639210123.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heath Latham, M.D has received a total of $9,676 in payments from pharmaceutical and medical device companies, with $15.13 received in 2024. These payments were reported across 36 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($6,525).

As a Medicare-enrolled provider, Latham has provided services to 2,340 Medicare beneficiaries, totaling 3,018 services with total Medicare billing of $223,869. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Other Specialties Pulmonary Disease
  • Location Kansas City, KS
  • Active Since 02/09/2007
  • Last Updated 09/11/2025
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1639210123

Products in Payments

  • STARLING SYSTEM (Device) $5,198
  • Renal - Acute (Device) $713.99
  • GIAPREZA (Drug) $161.50
  • DUPIXENT (Biological) $122.55
  • NUCALA (Biological) $62.86
  • TRELEGY ELLIPTA (Drug) $55.41
  • ANORO (Drug) $43.81
  • BEVESPI AEROSPHERE (Drug) $34.48
  • TEZSPIRE (Biological) $26.26
  • Arikayce (Drug) $16.24
  • AVYCAZ (Drug) $14.44
  • ANORO ELLIPTA (Drug) $12.60
  • DALVANCE (Drug) $10.41

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Kansas City